J & J arthritis drug goes up against Humira, with mixed results

(Reuters) - Johnson& Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Inc's top-selling Humira in a large trial.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news